Paolo Fortina

Sidney Kimmel Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

58h-index13.4kcitations386works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(34), Cancer-related Molecular Pathways(26), Cytokine Signaling Pathways and Interactions(24), Advanced biosensing and bioanalysis techniques(23), Microfluidic and Capillary Electrophoresis Applications(22)

Publications382 total

Geranylgeraniol Overcomes the Deleterious Effect of Nitrogen Containing Bisphosphonates on Osteoclasts by Promoting G-protein Expression
2025Open Access
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness
Clinical Cancer Research·2024Open Access
Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies
Clinical and Experimental Rheumatology·2024· 1 citedOpen Access
Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research
Clinical Chemistry and Laboratory Medicine (CCLM)·2024· 10 cited
Abstract 2102: Understanding the mechanism of action of rigosertib in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma through single cellanalysis
Cancer Research·2024
Supplementary Materials and Methods from <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
2023Open Access
Supplementary Table 2 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplementary Table 2 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplemental Table 1 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplementary Table 5 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplementary Methods; Supplementary Figures 1 through 9 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplemental table 4 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplementary Figures from <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
2023Open Access
Supplementary Materials and Methods from <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
2023Open Access
Supplemental table 4 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Data from <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
2023Open Access
Data from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplemental Table 3 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Data from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
Supplemental Table 1 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
2023Open Access
page 1 of 20Next →

Frequent Co-authors

Larry J. Kricka(10), Saul Surrey(9), Adam Ertel(8), Sankar Addya(6), Steven E. McKenzie(6), Peter Wilding(6), Mathew C. Casimiro(5), Richard G. Pestell(5), Terry Hyslop(5), Paul F. Bray(4), Paolo Gasparini(4), Nicholas J. Panaro(4), Massimo Cristofanilli(4), Agnieszka K. Witkiewicz(3), Michael P. Lisanti(3), Leonard C. Edelstein(3), Kathleen Delgrosso(3), Eric Londin(3), Phillipe Loher(3), Isidore Rigoutsos(3)